Skip to content

Oral Methadone in Cardiac Surgery

Oral Methadone In Cardiac Surgery

Status
Recruiting
Phases
Phase 4
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07221617
Acronym
OMICS
Enrollment
100
Registered
2025-10-28
Start date
2026-01-13
Completion date
2026-08-31
Last updated
2026-08-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Anesthesia, Cardiac Surgery, Pain, Postoperative

Brief summary

The purpose of this study is to compare the effects of administration of oral methadone preoperatively and intravenous methadone upon induction of general anesthesia on postoperative pain for patients undergoing elective cardiac surgery.

Interventions

DRUGMethadone, oral

Patients will receive 0.4mg/kg PO methadone immediately prior to transport to the operating room

DRUGMethadone, intravenously

Patients will receive 0.3mg/kg methadone intravenously after induction of general anesthesia

Sponsors

Mayo Clinic
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
TRIPLE (Subject, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

• Undergoing elective cardiac surgery

Exclusion criteria

* Chronic pain requiring opioid medications as an outpatient * Opioid use disorder on medication assistance treatment * Prolonged QTc \>500ms * Chronic kidney disease with eGFR \< 30mL/min * Documented cirrhosis * Intolerance to methadone * Admitted inpatient in an intensive care unit (ICU) immediately prior to surgery * Pregnancy at the time of surgery * Subsequent surgeries after index surgery

Design outcomes

Primary

MeasureTime frameDescription
Amount of opioid medication used 72 hours post-extubationFrom hospital admission for surgery to 72 hours after the patient is extubated postoperativelyOpioid medication used at 72 hours post-extubation will be reported in morphine milligram equivalents

Secondary

MeasureTime frameDescription
Amount of opioid medication used 24 hours post-extubationFrom hospital admission for surgery to 24 hours after the patient is extubated postoperativelyOpioid medication used at 24 hours post-extubation will be reported in morphine milligram equivalents
Amount of opioid medication used 48 hours post-extubationFrom hospital admission for surgery to 48 hours after the patient is extubated postoperativelyOpioid medication used at 48 hours post-extubation will be reported in morphine milligram equivalents
Amount of opioid medication required throughout hospitalizationFrom the time the patient is extubated until the time the patient leaves the hospital, approximately 10 days. Safety to leave the hospital is determined by the cardiac surgery team and can be several days after surgery or longer.Opioid medication required from extubation until hospital discharge will be reported in morphine milligram equivalents
Amount of opioid medication required prior to extubationFrom arrival in the ICU until extubation, approximately 6 hours. Safety of extubation is determined by the intensive care unit team and usually occurs within several hours of ICU arrival, although this can be variable.Opioid medication required between the end of surgery and extubation will be documented in morphine milligram equivalents.
Pain scores after extubation6 hours, 12 hours, 24 hours, 48 hours, and 72 hours after extubationPain will be assessed by nursing staff using a numerical rating scale from 0-10, with 0 being no pain and 10 being the worst pain imaginable.
Time to extubationFrom the time the patient arrives in the ICU intubated until the time they are successfully extubated, approximately 12 hours. Safety of extubation is determined by the ICU team and usually occurs within several hours, although this can be variable.This outcome will monitor the time in minutes from when a patient arrives in the ICU to the time the breathing tube is removed (extubation).

Countries

United States

Contacts

CONTACTAnesthesia Clinical Research Unit
Paul.Johar@mayo.edu866-265-9263
PRINCIPAL_INVESTIGATORKrishnan Ramanujan, M.D.

Mayo Clinic

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Aug 22, 2026